AI assistant
Sending…
ASSEMBLY BIOSCIENCES, INC. — Director's Dealing 2025
Apr 1, 2025
33081_dirs_2025-04-01_ad1bb349-e6e3-420e-be7b-779b353f6bea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2025-03-29
Reporting Person: Gaggar Anuj (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-29 | Stock Option (right to buy) | $10.62 | A | 24200 | Acquired | 2035-03-29 | Common Stock (24200) | Direct |
Footnotes
F1: Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2026; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2029.
More from ASSEMBLY BIOSCIENCES, INC.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
Mar 30
Regulatory Filings
2026
Mar 19
Regulatory Filings
2026
Mar 19
Major Shareholding Notification
2026
Feb 9
Regulatory Filings
2025
Dec 8
Regulatory Filings
2025
Nov 21